Ethical considerations accompany hereditary cancer testing, including testing minors and incidental findings.

• A. Informed consent, privacy, impact on life and reproductive decisions, incidental findings, and debate over testing minors for adult-onset syndromes
• B. Testing for incidental findings is not considered
• C. Testing minors is universally recommended
• D. Privacy is not a concern in genetic testing

Answer: (A)

Ethical considerations in hereditary cancer testing involve how information is obtained, interpreted, and shared, recognizing its impact on patients and their families. Informed consent requires that individuals understand that results can affect not only their own health but the health of relatives, and that some results may be uncertain or reveal incidental findings. Privacy matters because genetic information can influence insurability and discrimination, and decisions must be made about who can access and use the data. The impact on life and reproductive decisions is real, as risk information can drive choices about intensified surveillance, risk-reducing strategies, and family planning options, including implications for future pregnancies. Incidental findings are a key concern with broader genomic testing, raising questions about whether and how to disclose unrelated but actionable results, and about patient preferences for such information. The debate over testing minors for adult-onset syndromes hinges on protecting future autonomy and avoiding psychosocial or discrimination harms, usually favoring deferred testing unless there is a direct childhood medical benefit. Together, these elements capture why ethical considerations in hereditary cancer testing are comprehensive and ongoing.